Figure 1. Cervical cancer recurs after MPA therapy.

(A) Treatment regimens are depicted. K14E6/K14E7 mice were enrolled at 4−6 weeks of age. MPA, medroxyprogesterone acetate; E₂, estrogen. (B) Shown are representative images of H&E−stained cervical epithelium from indicated groups. Scale bar, 50 μm. (C) Shown are representative images of H&E−stained cervical cancer from indicated groups. Scale bar, 50 μm.